Skip to Main content Skip to Navigation
Journal articles

Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.

Abstract : AIDS-related mortality and the rate of progression to AIDS have dramatically decreased since the advent of highly active antiretroviral treatment (HAART). The overall benefit from antiretroviral HIV treatment has, however, been lesser in HIV-infected injecting drug users (IDUs) than in other patient groups (e.g. men who have sex with men). Poorer outcomes in HIV-infected IDUs are related to a variety of factors, including increased rates of non-HIV-related deaths, hepatitis C, delayed access to effective treatment, lower adherence to care and treatment regimens, continuation of illicit drug use, depression and negative life events. The available evidence strongly suggests the need for the large-scale implementation of comprehensive treatment and care strategies for IDUs that include both treatment of drug dependence and HAART.
Document type :
Journal articles
Complete list of metadatas

Cited literature [22 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00174744
Contributor : Nadine Kaniewski <>
Submitted on : Tuesday, September 25, 2007 - 3:41:02 PM
Last modification on : Wednesday, September 16, 2020 - 4:55:48 PM
Long-term archiving on: : Friday, April 9, 2010 - 2:48:52 AM

Identifiers

Citation

France Lert, Michel Kazatchkine. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.. International Journal of Drug Policy, Elsevier, 2007, 18 (4), pp.255-61. ⟨10.1016/j.drugpo.2007.05.002⟩. ⟨inserm-00174744⟩

Share

Metrics

Record views

516

Files downloads

1239